Olfactory discrimination predicts cognitive decline among community-dwelling older adults

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Sohrabi, H R ^a,b   Bates, K A ^a,b,c   Weinborn, M G ^c   Johnston, A N B ^d   Bahramian, A ^b   Taddei, K ^a,b   Laws, S M ^a,b   Rodrigues, M ^a,b   Morici, M ^a   Howard, M ^a   Martins, G ^a,b   MacKay Sim, A ^d   Gandy, S E ^e   Martins, R N ^a,b,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; COMMUNITY LIVING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OLFACTORY DISCRIMINATION; SMELLING; AGNOSIA; ALZHEIMER DISEASE; COHORT ANALYSIS; DISEASE COURSE; GENETICS; GENOTYPE; INDEPENDENT LIVING; LONGITUDINAL STUDY; MIDDLE AGED; ODOR; PERCEPTIVE DISCRIMINATION; PERCEPTIVE THRESHOLD; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RECOGNITION; SMELLING DISORDER; STATISTICS;

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; AGED, 80 AND OVER; AGNOSIA; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COHORT STUDIES; DISCRIMINATION (PSYCHOLOGY); DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; INDEPENDENT LIVING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODORS; OLFACTION DISORDERS; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; RECOGNITION (PSYCHOLOGY); SENSORY THRESHOLDS; SMELL;

EID: 84861317787     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.43     Document Type: Article

References (92)

1. Nordin S, Murphy C. Odor memory in normal aging and Alzheimer's disease. Ann N Y Acad Sci 1998; a 855: 686-693.
2. Doty RL, Perl DP, Steele JC, Chen KM, Pierce Jr JD, Reyes P et al. Olfactory dysfunction in three neurodegenerative diseases. Geriatrics 1991; a 46(Suppl 1): 47-51.
3. Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR. Olfactory deficits and Alzheimer's disease. Biol Psychiatry 1986; a 21: 116-118.
4. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2008; a 29: 693-706.
5. Lehrner J, Pusswald G, Gleiss A, Auff E, Dal-Bianco P. Odor identification and selfreported olfactory functioning in patients with subtypes of mild cognitive impairment. Clin Neuropsychol 2009; a 23: 818-830.
6. Murphy C, Bacon AW, Bondi MW, Salmon DP. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci 1998; a 30: 744-750.
7. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD et al. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status. Neurology 1999; a 53: 1480-1487.
8. Sohrabi HR, Bates KA, Rodrigues M, Taddei K, Laws SM, Lautenschlager NT et al. Olfactory dysfunction is associated with subjective memory complaints in communitydwelling elderly individuals. J Alzheimers Dis 2009; a 17: 135-142.
9. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer's disease. Int Symp Olfaction Taste: Ann N Y Acad Sci 2009; a 1170: 730-735.
10. Wesson DW, Levy E, Nixon RA, Wilson DA. Olfactory dysfunction correlates with amyloidbeta burden in an Alzheimer's disease mouse model. J Neurosci 2010; a 30: 505-514.
11. Kovacs T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: Olfactory bulb is involved in early Braak's stages. Neuroreport 2001; a 12: 285-288.
12. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relation of cerebral Alzheimer's disease pathology to odor identification in old age. J Neurol Neurosurg Psychiatry 2007; a 78: 30-35.
13. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol 2003; a 29: 503-510.
14. Jellinger KA, Attems J. Alzheimer pathology in the olfactory bulb. Neuropathol Appl Neurobiol 2005; a 31: 203.
15. Ghanbari HA, Ghanbari K, Harris PL, Jones PK, Kubat Z, Castellani RJ et al. Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients. Aging Cell 2004; a 3: 41-44.
16. Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C et al. Functional representation of olfactory impairment in early Alzheimer's disease. J Alzheimers Dis 2010; a 22: 581-591.
17. Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatrics Soc 2008; a 56: 1517-1521.
18. Sakuma K, Nakashima K, Takahashi K. Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients. Psychiatry Clin Neurosci 1996; a 50: 35-40.
19. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998; a 55: 84-90.
20. Eibenstein A, Fioretti AB, Lena C, Rosati N, Amabile G, Fusetti M. Modern psychophysical tests to assess olfactory function. Neurol Sci 2005; a 26: 147-155.
21. De Wijk RA, Cain WS. Odor quality: discrimination versus free and cued identification. Percept Psychophys 1994; a 56: 12-18.
22. Richardson JT, Zucco GM. Cognition and olfaction: A review. Psychol Bull 1989; a 105: 352-360.
23. Schab FR. Odor memory: Taking stock. Psychol Bull 1991; a 109: 242-251.
24. Swan GE, Carmelli D. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 2002; a 21: 58-67.
25. Elsner RJF. Odor memory and aging. Aging Neuropsychol Cogn 2001; a 8: 284-306.
26. Stevenson RJ, Case TI, Tomiczek C. Resistance to interference of olfactory perceptual learning. Psychol Rec 2007; a 57: 103-116.
27. Dade LA, Zatorre RJ, Jones-Gotman M. Olfactory learning: convergent findings from lesion and brain imaging studies in humans. Brain 2002; a 125(Part 1): 86-101.
28. Buchanan TW, Tranel D, Adolphs R. A specific role for the human amygdala in olfactory memory. Learn Mem 2003; a 10: 319-325.
29. Levy DA, Hopkins RO, Squire LR. Impaired odor recognition memory in patients with hippocampal lesions. Learn Memory 2004; a 11: 794-796.
30. Duda JE. Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 2010; a 289: 49-54.
31. McShane R, Williams SS, Williams J, Combrinck M, Christie S, Smith AD. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 2009; a 80: 667-670.
32. Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA et al. Prevalence of smell loss in Parkinson's disease: A multicenter study. Parkinsonism Relat Disord 2009; a 15: 490-494.
33. Arnold SE, Smutzer GS, Trojanowski JQ, Moberg PJ. Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia. Ann N Y Acad Sci 1998; a 855: 762-775.
34. Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC, Roalf DR et al. Olfactory functioning in schizophrenia: Relationship to clinical, neuropsychological, and volumetric MRI measures. J Clin Exp Neuropsychol 2006; a 28: 1444-1461.
35. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord 2003; a 18: 364-372.
36. Burns A. Might olfactory dysfunction be a marker of early Alzheimer's disease? Lancet 2000; a 355: 84-85.
37. Bates KA, Sohrabi HR, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K et al. Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers. J Alzheimer's Dis: JAD 2009; a 17: 305-318.
38. Lau S, Bates KA, Sohrabi HR, Rodrigues M, Martins G, Dhaliwal SS et al. Functional effects of genetic polymorphism in inflammatory genes in subjective memory complainers. Neurobiol Aging 2012; a 33: 1054-1056.
39. Sohrabi HR, Bates KA, Rodrigues M, Taddei K, Martins G, Laws SM et al. The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Eepsilon4 carriers and non-carriers. J Alzheimer's Dis: JAD 2009; a 17: 69-79.
40. Folstein MF, Folstein SE, McHugh PR. Mini-mental state'': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; a 12: 189-198.
41. Roth M, Huppert FA, Mountjoy CQ, Tym E. Cambridge Cognitive Examination-Revised (CAMCOG-R). Cambridge University Press: Cambridge, 1999.
42. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G.'Sniffin' sticks': Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; a 22: 39-52.
43. Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C et al. Olfactory screening test in mild cognitive impairment. Neurol Sci 2005; a 26: 156-160.
44. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G.'Sniffin' sticks': Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; a 22: 39-52.
45. Wolfensberger M, Schnieper I, Welge-Lussen A. Sniffin'Sticks: A new olfactory test battery. Acta Oto-Laryngol 2000; a 120: 303-306.
46. Roth M, Huppert FA, Mountjoy CQ, Tym E. CAMDEX-R. Cambridge University Press: Cambridge, 1998.
47. Molloy DW, Standish TI. A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr 1997; a 9(Suppl 1): 87-94; a discussion 143-50.
48. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; a 31: 545-548.
49. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; a 337: 1158-1159.
50. Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the'Sniffin' Sticks' including tests of odor identification, odor discrimination, and olfactory thresholds: An upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007; a 264: 237-243.
51. Mackay-Sim A, Grant L, Owen C, Chant D, Silburn P. Australian norms for a quantitative olfactory function test. J Clin Neurosci 2004; a 11: 874-879.
52. Suzuki Y, Yamamoto S, Umegaki H, Onishi J, Mogi N, Fujishiro H et al. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease. Int J Geriatr Psych 2004; a 19: 727-733.
53. Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX et al. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Mov Disord 2010; a 25: 2099-2104.
54. Velayudhan L, Lovestone S. Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil. J Clin Psychopharmacol 2009; a 29: 387-390.
55. Wilson RS, Arnold SE, Tang Y, Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology 2006; a 26: 61-67.
56. Wilson RS, Schneider JA, Arnold SE, Tang YX, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiat 2007; a 64: 802-808.
57. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000; a 157: 1399-1405.
58. Olofsson JK, Nordin S, Wiens S, Hedner M, Nilsson LG, Larsson M. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol Aging 2010; a 31: 567-577.
59. Bacon AW, Bondi MW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 1998; a 855: 723-731.
60. Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 2007; a 45: 1823-1831.
61. Benarroch EE. Olfactory system: Functional organization and involvement in neurodegenerative disease. Neurology 2010; a 75: 1104-1109.
62. Albers MW, Tabert MH, Devanand DP. Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep 2006; a 6: 379-386.
63. Corwin J, Serby M, Rotrosen J. Olfactory deficits in AD: What we know about the nose. Neurobiol Aging 1986; a 7: 580-582.
64. Martin C, Beshel J, Kay LM. An olfacto-hippocampal network is dynamically involved in odor-discrimination learning. J Neurophysiol 2007; a 98: 2196-2205.
65. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging 2009; a 30: 507-514.
66. Finkel D, Pedersen NL, Larsson M. Olfactory functioning and cognitive abilities: A twin study. J Gerontol B Psychol Sci Soc Sci 2001; a 56: P226-P233.
67. Mackay-Sim A, Johnston AN, Owen C, Burne TH. Olfactory ability in the healthy population: Reassessing presbyosmia. Chem Senses 2006; a 31: 763-771.
68. Larsson M, Finkel D, Pedersen NL. Odor identification: Influences of age, gender, cognition, and personality. J Gerontol B-Psychol 2000; a 55: 304-310.
69. Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA. Lewy bodies and olfactory dysfunction in old age. Chem Senses 2011; a 36: 367-373.
70. Walker JC, Hall SB, Walker DB, Kendal-Reed MS, Hood AF, Niu XF. Human odor detectability: New methodology used to determine threshold and variation. Chem Senses 2003; a 28: 817-826.
71. Dulay MF, Murphy C. Olfactory acuity and cognitive function converge in older adulthood: support for the common cause hypothesis. Psychol Aging 2002; a 17: 392-404.
72. Engen T, Pfaffmann C. Absolute judgments of odor quality. J Exp Psychol 1960; a 59: 214-219.
73. Campbell IM, Gregson RAM. Olfactory short term memory in normal, schizophrenic and brain-damaged cases. Aust J Psychol 1972; a 24: 179-185.
74. Herz RS, Engen T. Odor memory: Review and analysis. Psychon B Rev 1996; a 3: 300-313.
75. Larsson M. Semantic factors in episodic recognition of common odors in early and late adulthood: A review. Chem Senses 1997; a 22: 623-633.
76. Larsson M, Nilsson LG, Olofsson JK, Nordin S. Demographic and cognitive predictors of cued odor identification: Evidence from a population-based study. Chem Senses 2004; a 29: 547-554.
77. Makowska I, Kloszewska I, Grabowska A, Szatkowska I, Rymarczyk K. Olfactory deficits in normal aging and Alzheimer's disease in the polish elderly population. Arch Clin Neuropsychol 2011; a 26: 270-279.
78. Eichenbaum H. Using olfaction to study memory. Ann N Y Acad Sci 1998; a 855: 657-669.
79. Powell TP, Cowan WM, Raisman G. The central olfactory connexions. J Anat 1965; a 99(Part 4): 791-813.
80. Savic I, Gulyas B, Larsson M, Roland P. Olfactory functions are mediated by parallel and hierarchical processing. Neuron 2000; a 26: 735-745.
81. Riedel G, Micheau J. Function of the hippocampus in memory formation: desperately seeking resolution. Prog Neuropsychopharmacol Biol Psychiatry 2001; a 25: 835-853.
82. Izquierdo I, Medina JH. Memory formation: The sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 1997; a 68: 285-316.
83. Wang SH, Morris RG. Hippocampal-neocortical interactions in memory formation, consolidation, and reconsolidation. Annu Rev Psychol 2010; a 61: 49-79, C1-4.
84. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Biol 2011; a 3: A006189.
85. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; a 82: 239-259.
86. Averback P. Two new lesions in Alzheimer's disease. Lancet 1983; a 2: 1203.
87. Ohm TG, Muller H, Braak E. Calbindin-D-28k-like immunoreactive structures in the olfactory bulb and anterior olfactory nucleus of the human adult: distribution and cell typology-partial complementarity with parvalbumin. Neuroscience 1991; a 42: 823-840.
88. Lojkowska W, Sawicka B, Gugala M, Sienkiewicz-Jarosz H, Bochynska A, Scinska A et al. Follow-up study of olfactory deficits, cognitive function, and volume loss of medial temporal lobe structures in patients with mild cognitive impairment. Curr Alzheimer Res 2011; a 8: 689-698.
89. Heinik J, Solomesh I. Validity of the Cambridge Cognitive Examination-Revised new Executive Function Scores in the diagnosis of dementia: some early findings. J Geriatr Psychiatry Neurol 2007; a 20: 22-28.
90. Verhoeven CL, Schepers VP, Post MW, van Heugten CM. The predictive value of cognitive impairments measured at the start of clinical rehabilitation for health status 1 year and 3 years poststroke. Int J Rehabil Res 2011; a 34: 38-43.
91. Bahar-Fuchs A, Moss S, Rowe C, Savage G. Olfactory performance in AD, aMCI, and healthy ageing: A unirhinal approach. Chem Senses 2010; a 35: 855-862.
92. Foster J, Sohrabi H, Verdile G, Martins R. Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction. Int Psychogeriatr 2008; a 20: 853-855.